Earnings History Data for Rigel Pharmaceuticals, Inc. (RIGL) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals, Inc. is a clinical-stage drug development company that discovers and develops novel, small-molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases. Its goal is to file one new investigative new drug application in a significant indication each year. The Company's pioneering research focuses on intracellular signaling pathways and related targets that are critical to disease mechanisms. Rigel's productivity has resulted in strategic collaborations with large pharmaceutical partners to develop and market our product candidates. We have product development programs in inflammatory/autoimmune diseases such as rheumatoid arthritis, thrombocytopenia, and asthma and allergy, as well as in cancer.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
07-11-2024	AH		RIGL	Rigel Pharmaceuticals, Inc.	255.13	0.70	0.01	-0.30	Rigel Pharmaceuticals GAAP EPS of $0.70 beats by $0.63, revenue of $55.3M beats by $13.37M [11/7/2024 4:11 PM]	22.39	6.95 (45.01%)	17.16	1.72 (11.14%)	7.48 - 22.67	1,183,370	120,000	16,406
Rigel Pharmaceuticals GAAP EPS of $0.70 beats by $0.63, revenue of $55.3M beats by $13.37M [11/7/2024 4:11 PM] Rigel stock rallies 36% after Q3 earnings beat [11/8/2024 12:24 PM] Rigel Reports Third Quarter 2024 Financial Results and Provides Business Update [2024-11-07 04:01PM] Rigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To Expect [Nov-06-24 07:42AM]
06-08-2024	AH		RIGL	Rigel Pharmaceuticals, Inc.	176.11	-0.06	-0.37	-0.40	Rigel Pharmaceuticals GAAP EPS of -$0.06 beats by $0.14, revenue of $36.84M beats by $3.14M [8/6/2024 4:37 PM]	9.92	0.59 (6.32%)	10.40	1.07 (11.47%)	7.12 - 17.30	88,597	90,000	1,671
Rigel Pharmaceuticals GAAP EPS of -$0.06 beats by $0.14, revenue of $36.84M beats by $3.14M [8/6/2024 4:37 PM]
07-05-2024	AH		RIGL	Rigel Pharmaceuticals	202.00	-0.05	-0.03	0.00	Rigel Pharmaceuticals GAAP EPS of -$0.05 misses by $0.02, revenue of $29.53M misses by $1.94M [5/7/2024 4:32 PM]	0.9924	-0.20 (-16.60%)	1.10	-0.09 (-7.56%)	0.71 - 1.96	3,338,349	1,690,000	26,226
Rigel Pharmaceuticals GAAP EPS of -$0.05 misses by $0.02, revenue of $29.53M misses by $1.94M [5/7/2024 4:32 PM]
05-03-2024	AH		RIGL	Rigel Pharmaceuticals	265.00	N/A	-0.03	0.00	Rigel Pharmaceuticals GAAP EPS of $0.00 beats by $0.02, revenue of $35.8M beats by $2.39M [3/5/2024 4:08 PM]	1.56	0.08 (5.74%)	1.51	0.03 (2.03%)	0.71 - 1.96	3,305,522	1,450,000	23,939
Rigel Pharmaceuticals GAAP EPS of $0.00 beats by $0.02, revenue of $35.8M beats by $2.39M [3/5/2024 4:08 PM]
07-11-2023	AH		RIGL	Rigel Pharmaceuticals, Inc.	153.63	-0.03	-0.06	-0.11	Rigel Pharmaceuticals GAAP EPS of -$0.03 beats by $0.04, revenue of $28.13M beats by $0.93M [11/7/2023 4:15 PM]	0.8810	0.01 (1.21%)	0.91	0.04 (4.54%)	0.67 - 2.04	484,782	550,000	10,008
Rigel Pharmaceuticals GAAP EPS of -$0.03 beats by $0.04, revenue of $28.13M beats by $0.93M [11/7/2023 4:15 PM]
01-08-2023	AH		RIGL	Rigel Pharmaceuticals, Inc.	230.98	-0.04	-0.08	-0.08	Rigel Pharmaceuticals GAAP EPS of -$0.04 beats by $0.04, revenue of $26.89M beats by $1.19M [8/1/2023 4:30 PM]	1.30	-0.03 (-1.88%)	1.32	-0.01 (-0.75%)	0.67 - 2.04	1,291,652	1,130,000	10,192
Rigel Pharmaceuticals GAAP EPS of -$0.04 beats by $0.04, revenue of $26.89M beats by $1.19M [8/1/2023 4:30 PM]
02-05-2023	AH	4:00 PM ET (May 2)	RIGL	Rigel Pharmaceuticals, Inc.	194.49	-0.08	-0.09	-0.16	Rigel Pharmaceuticals GAAP EPS of -$0.08 beats by $0.02, revenue of $26.07M beats by $2M [5/2/2023 4:32 PM]	1.16	0.02 (1.75%)	1.18	0.04 (3.51%)	0.64 - 2.71	1,677,560	1,360,000	13,212
Rigel Pharmaceuticals GAAP EPS of -$0.08 beats by $0.02, revenue of $26.07M beats by $2M [5/2/2023 4:32 PM]
07-03-2023	AH	4:00 PM ET (Mar 7)	RIGL	Rigel Pharmaceuticals, Inc.	266.17	0.01	-0.09	-0.13	Rigel Pharmaceuticals GAAP EPS of $0.34 beats by $0.80, revenue of $120.24M beats by $27.04M [3/7/2023 4:02 PM]	1.78	0.31 (21.09%)	1.79	0.32 (21.77%)	0.64 - 3.52	20,964,529	2,550,000	8,699,203
Rigel Pharmaceuticals GAAP EPS of $0.34 beats by $0.80, revenue of $120.24M beats by $27.04M [3/7/2023 4:02 PM] Rigel Pharma, with beats on quarterly top and bottom lines, surges 19% [3/7/2023 4:48 PM]
03-11-2022	AH	4:00 PM ET (Nov 3)	RIGL	Rigel Pharmaceuticals, Inc.	130.18	-0.11	-0.13	-0.12	Rigel Pharmaceuticals GAAP EPS of -$0.11 beats by $0.03, revenue of $22.4M misses by $0.21M [11/3/2022 4:06 PM]	0.7439	0.02 (2.54%)	0.72	0.0 (-0.21%)	0.64 - 3.52	837,499	1,650,000	13,580
Rigel Pharmaceuticals GAAP EPS of -$0.11 beats by $0.03, revenue of $22.4M misses by $0.21M [11/3/2022 4:06 PM] Another Clinical Trial Setback For Rigel Pharma's Lead Program, This Time For COVID-19 [Nov-02-22 06:41AM] Rigel Reports Third Quarter 2022 Financial Results and Provides Business Update [Nov-03-22 04:01PM] Rigel Announces Five Poster Presentations at the Upcoming 64th American Society of Hematology Annual Meeting and Exposition [Nov-03-22 09:24AM]
02-08-2022	AH	4:00 PM ET (Aug 2)	RIGL	Rigel Pharmaceuticals, Inc.	196.14	-0.08	-0.12	-0.08	Rigel Pharmaceuticals GAAP EPS of -$0.08 beats by $0.04, revenue of $29.82M beats by $6.17M [8/2/2022 4:19 PM]	1.39	0.09 (6.92%)	1.57	0.27 (20.77%)	0.64 - 4.24	8,858,585	2,600,000	4,182,092
Rigel Pharmaceuticals GAAP EPS of -$0.08 beats by $0.04, revenue of $29.82M beats by $6.17M [8/2/2022 4:19 PM] Rigel rises 17% on strong Q2 result [8/3/2022 10:58 AM] Rigel Reports Second Quarter 2022 Financial Results and Provides Business Update [Aug-02-22 04:02PM] Rigel Pharmaceuticals and Forma Therapeutics Announce Licensing Agreement for Olutasidenib, a Novel Mutant IDH1 Inhibitor for the Potential Treatment of Relapsed or Refractory Acute Myeloid Leukemia [Aug-02-22 04:01PM] Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates [Aug-02-22 06:05PM]
03-05-2022	AH	4:00 PM ET (May 3)	RIGL	Rigel Pharmaceuticals	421.00	-0.16	-0.12	0.00	Rigel Pharmaceuticals GAAP EPS of -$0.16 misses by $0.02, revenue of $16.74M misses by $0.8M [5/3/2022 4:12 PM]	2.65	0.17 (6.85%)	2.49	0.01 (0.40%)	2.19 - 4.62	1,631,079	1,530,000	4,297
Rigel Pharmaceuticals GAAP EPS of -$0.16 misses by $0.02, revenue of $16.74M misses by $0.8M [5/3/2022 4:12 PM] Rigel Reports First Quarter 2022 Financial Results and Provides Business Update [May-03-22 04:01PM] Rigel Pharmaceuticals (RIGL) Reports Q1 Loss, Misses Revenue Estimates [May-03-22 05:35PM]
01-03-2022	AH	4:00 PM ET (Mar 1)	RIGL	Rigel Pharmaceuticals, Inc.	432.65	-0.13	-0.13	-0.11	Rigel Pharmaceuticals GAAP EPS of -$0.13 in-line, revenue of $20.41M misses by $0.79M [3/1/2022 4:31 PM]	3.02	0.51 (20.12%)	2.51	0.0 (0.00%)	2.19 - 4.62	3,977,672	1,540,000	19,290
Rigel Pharmaceuticals GAAP EPS of -$0.13 in-line, revenue of $20.41M misses by $0.79M [3/1/2022 4:31 PM] Rigel Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update [Mar-01-22 04:01PM] Rigel Pharmaceuticals (RIGL) Reports Q4 Loss, Misses Revenue Estimates [Mar-01-22 05:45PM]
02-11-2021	AH	4:00 PM ET (Nov 2)	RIGL	Rigel Pharmaceuticals, Inc.	563.81	-0.12	-0.10	-0.08	Rigel Pharmaceuticals EPS beats by $0.14, misses on revenue [11/2/2021 4:05 PM]	3.45	-0.11 (-3.22%)	3.22	-0.35 (-9.80%)	2.46 - 5.50	3,482,752	1,020,000	153,087
Rigel Pharmaceuticals EPS beats by $0.14, misses on revenue [11/2/2021 4:05 PM] Rigel Reports Third Quarter 2021 Financial Results and Provides Business Update [Nov-02-21 04:01PM] Rigel Pharmaceuticals (RIGL) Reports Q3 Loss, Lags Revenue Estimates [Nov-02-21 05:35PM]
03-08-2021	AH	4:00 PM ET (Aug 3)	RIGL	Rigel Pharmaceuticals, Inc.	680.66	-0.08	-0.11	-0.10	Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue [8/3/2021 4:07 PM]	3.73	-0.05 (-1.32%)	3.73	0.0 (0.00%)	2.14 - 5.50	2,323,272	1,240,000	12,287
Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue [8/3/2021 4:07 PM] Rigel Reports Second Quarter 2021 Financial Results and Provides Business Update [Aug-03-21 04:01PM] Rigel Pharmaceuticals (RIGL) Reports Q2 Loss, Tops Revenue Estimates [Aug-03-21 05:45PM]
05-05-2021	AH	4:00 PM ET (May 5)	RIGL	Rigel Pharmaceuticals, Inc.	632.85	0.22	0.01	0.13	Rigel Pharmaceuticals EPS beats by $0.26, beats on revenue [5/5/2021 4:05 PM]	3.26	-0.21 (-6.05%)	3.26	0.0 (0.00%)	1.70 - 5.50	3,256,088	2,000,000	35,669
Rigel Pharmaceuticals, Inc. to Host Earnings Call [May-05-21 02:30PM] Rigel Reports First Quarter 2021 Financial Results and Provides Business Update [May-05-21 04:01PM] Rigel Pharmaceuticals (RIGL) Tops Q1 Earnings and Revenue Estimates [May-05-21 06:25PM]
02-03-2021	AH	4:00 PM ET (Mar 2)	RIGL	Rigel Pharmaceuticals, Inc.	701.27	-0.11	-0.10	-0.10	Rigel Pharmaceuticals EPS in-line, beats on revenue [3/2/2021 4:03 PM]	3.85	-0.46 (-10.57%)	4.25	-0.05 (-1.28%)	1.23 - 5.50	4,501,142	6,746,006	17,390
Rigel Pharmaceuticals EPS in-line, beats on revenue [3/2/2021 4:03 PM] Rigel Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update [Mar-02-21 04:01PM]
05-11-2020	AH	4:00 PM ET (Nov 5)	RIGL	Rigel Pharmaceuticals, Inc.	430.77	-0.08	-0.12	-0.07	Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue [11/5/2020 4:06 PM]	2.61	-0.13 (-4.74%)	2.50	-0.24 (-8.76%)	1.23 - 5.24	2,978,718	2,392,024	26,785

04-08-2020	AH	4:00 PM ET (Aug 4)	RIGL	Rigel Pharmaceuticals, Inc.	387.71	-0.10	-0.13	-0.12	Rigel Pharmaceuticals EPS beats by $0.04, beats on revenue [8/4/2020 4:02 PM]	2.51	0.05 (2.03%)	2.90	0.44 (17.89%)	1.23 - 5.24	6,491,518	4,629,404	333,397

05-05-2020	AH	4:00 PM ET (May 5)	RIGL	Rigel Pharmaceuticals, Inc.	288.25	0.13	0.13	-0.11	Rigel Pharmaceuticals EPS in-line, misses on revenue [5/5/2020 4:06 PM]	1.96	0.11 (5.95%)	0.0	0.0 (0.00%)	1.23 - 3.10	2,405,506	2,328,339	0